A new international survey led by the International Osteoporosis Foundation reveals that adults living with hypophosphatemic osteomalacia (HO), a rare metabolic bone disorder, face a substantial and often under-recognized disease burden, with wide variation in how the condition is managed worldwide.
Continue Reading this article here
